Teva Pharmaceutical Industries reported $233M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Aspen Pharmacare ZAR 1.47B 4.94B Dec/2025
Cipla INR 8.78B 884.9M Sep/2026
Dr.Reddys Laboratories INR 9.25B 4.81B Sep/2026
Guangzhou Baiy CNY 395.63M 83.47M Sep/2026
Jiangsu Hengrui CNY 2.46B 274.79M Sep/2026
Kalbe Farma IDR 817.43B 73.1B Sep/2026
Richter Gedeon HUF 38.26B 27.02B Jun/2026
Sh Fosun Pharma CNY 946.02M 95.38M Sep/2026
Sun Pharmaceuticals INR 19.89B 9.06B Sep/2026
Teva Pharmaceutical Industries USD 233M 809M Sep/2026